Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Cytosorbents Crp

Current price
0.8 USD +0.0092 USD (+1.16%)
Last closed 0.79 USD
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 40 892 720 USD
Yield for 12 month -76.74 %
21.11.2021 - 28.11.2021

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology in the United States, Germany, and internationally. Its flagship product is CytoSorb, an extracorporeal cytokine adsorber for adjunctive therapy in the treatment of sepsis, adjunctive therapy in other critical care applications, prevention, and treatment of perioperative complications, and maintaining or enhancing the quality of solid organs harvested from donors for organ transplant; and offers VetResQ, a device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals. The company also develops CytoSorb-XL, a device for adjunctive therapy in the treatment of sepsis and other critical illnesses; HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients, and removal of anti-A and anti-B blood group antibodies from whole blood and plasma; K+ontrol for treatment of severe hyperkalemia in patients with life-threatening conditions; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it develops BetaSorb, a device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; DrugSorb, a device to remove drugs and chemicals from the blood; and DrugSorb-ATR, an antithrombotic removal system. The company was formerly known as MedaSorb Technologies Corporation and changed its name to Cytosorbents Corporation in May 2010. Cytosorbents Corporation was founded in 1997 and is headquartered in Princeton, New Jersey. Address: 305 College Road East, Princeton, NJ, United States, 08540

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

3.63 USD

P/E ratio

Dividend Yield

Current Year

+36 349 379 USD

Last Year

+29 360 000 USD

Current Quarter

+9 786 292 USD

Last Quarter

+8 668 215 USD

Current Year

+22 392 023 USD

Last Year

+15 404 000 USD

Current Quarter

+6 570 579 USD

Last Quarter

+5 311 280 USD

Key Figures CTSO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -25 706 084 USD
Operating Margin TTM -50.33 %
PE Ratio
Return On Assets TTM -32.65 %
PEG Ratio
Return On Equity TTM -115.03 %
Wall Street Target Price 3.63 USD
Revenue TTM 36 686 176 USD
Book Value 0.35 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 3.6 %
Dividend Yield
Gross Profit TTM 20 733 057 USD
Earnings per share -0.59 USD
Diluted Eps TTM -0.59 USD
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin -75.07 %

Dividend Analytics CTSO

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CTSO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:25
Payout Ratio
Last Split Date 05.12.2014
Dividend Date

Stock Valuation CTSO

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 7.734
Enterprise Value Revenue 1.6576
Price Sales TTM 1.3025
Enterprise Value EBITDA -1.7656
Price Book MRQ 2.0341

Financials CTSO

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CTSO

For 52 weeks

0.75 USD 4.29 USD
50 Day MA 0.87 USD
Shares Short Prior Month 1 462 019
200 Day MA 1.22 USD
Short Ratio 13.89
Shares Short 1 524 296
Short Percent 2.77 %

Dynamics of changes in the value of assets




449.78 USD Microsoft Corporation +4.08 (+0.92%)
Detailed analytics

ETF funds



203.20 CHF UBS SLI A-dis -1.46 (-0.64%)
Detailed analytics



2320.99 USD Gold -0.16 (-0.01%)
Detailed analytics